Obesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA medications on health trends.
Obesity prevalence and BMI decrease in the US for the first time in a decade
- Post author:
- Post published:December 16, 2024
- Post category:uncategorized